Paper39596381
Roscovitine, a CDK Inhibitor, Reduced Neuronal Toxicity of mHTT by Targeting HTT Phosphorylation at S1181 and S1201 In Vitro.
Liu H and 9 others. Int J Mol Sci, 2024. Cited by 7 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Roscovitine, a CDK Inhibitor, Reduced Neuronal Toxicity of mHTT by Targeting HTT Phosphorylation at S1181 and S1201 In Vitro. Papers, record 39596381. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39596381
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Roscovitine, a CDK Inhibitor, Reduced Neuronal Toxicity of mHTT by Targeting HTT Phosphorylation at S1181 and S1201 In Vitro.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Roscovitine | Major topic |
| Huntingtin Protein | Major topic |
| Neurons | Major topic |
| Cyclin-Dependent Kinase 5 | Major topic |
| Phosphorylation | |
| Animals | |
| Mice | |
| Humans | |
| Huntington Disease | |
| Protein Kinase Inhibitors | |
| Protein Processing, Post-Translational | |
| CDC2 Protein Kinase |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 NS124084 | NINDS NIH HHS | United States | R01NS124084 | PubMed | NIH RePORTER |
| R01 NS086452 | NINDS NIH HHS | United States | R01NS086452 | PubMed | NIH RePORTER |
| R21 NS135139 | NINDS NIH HHS | United States | R21NS135139 | PubMed | NIH RePORTER |
| R01NS086452 | NIH HHS | United States | R01NS086452 | PubMed | NIH RePORTER |
| R21 NS125063 | NINDS NIH HHS | United States | R21NS125063 | PubMed | NIH RePORTER |
| R21 NS125063 | NIH HHS | United States | R21NS125063 | PubMed | NIH RePORTER |
References88
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31,981,925 | R-Roscovitine Improves Motoneuron Function in Mouse Models for Spinal Muscular Atrophy. | iScience | 2020 | https://conductscience.org/library/papers/31981925 | PubMed |
| 2 | 17,173,700 | Multiple pathways contribute to the pathogenesis of Huntington disease. | Mol Neurodegener | 2006 | https://conductscience.org/library/papers/17173700 | PubMed |
| 3 | 31,189,016 | Overexpression of the Cdk5 inhibitory peptide in motor neurons rescue of amyotrophic lateral sclerosis phenotype in a mouse model. | Hum Mol Genet | 2019 | https://conductscience.org/library/papers/31189016 | PubMed |
| 4 | 21,163,446 | Huntington's disease: from molecular pathogenesis to clinical treatment. | Lancet Neurol | 2011 | https://conductscience.org/library/papers/21163446 | PubMed |
| 5 | 30,185,623 | N-terminal Huntingtin (Htt) phosphorylation is a molecular switch regulating Htt aggregation, helical conformation, internalization, and nuclear targeting. | J Biol Chem | 2018 | https://conductscience.org/library/papers/30185623 | PubMed |
| 6 | 24,353,748 | Decreasing Levels of the cdk5 Activators, p25 and p35, Reduces Excitotoxicity in Striatal Neurons. | J Huntingtons Dis | 2012 | https://conductscience.org/library/papers/24353748 | PubMed |
| 7 | 25,938,685 | The effect of circadian rhythm on pharmacokinetics and metabolism of the Cdk inhibitor, roscovitine, in tumor mice model. | Chronobiol Int | 2015 | https://conductscience.org/library/papers/25938685 | PubMed |
| 8 | 21,044,075 | Regulation and role of cyclin-dependent kinase activity in neuronal survival and death. | J Neurochem | 2010 | https://conductscience.org/library/papers/21044075 | PubMed |
| 9 | 34,888,656 | Interaction of huntingtin with PRMTs and its subsequent arginine methylation affects HTT solubility, phase transition behavior and neuronal toxicity. | Hum Mol Genet | 2022 | https://conductscience.org/library/papers/34888656 | PubMed |
| 10 | 27,693,427 | ESC-Derived BDNF-Overexpressing Neural Progenitors Differentially Promote Recovery in Huntington's Disease Models by Enhanced Striatal Differentiation. | Stem Cell Reports | 2016 | https://conductscience.org/library/papers/27693427 | PubMed |
| 11 | 11,978,846 | Cyclin-dependent kinase 5 is required for associative learning. | J Neurosci | 2002 | https://conductscience.org/library/papers/11978846 | PubMed |
| 12 | 17,160,145 | The role of CDK5/P25 formation/inhibition in neurodegeneration. | Drug News Perspect | 2006 | https://conductscience.org/library/papers/17160145 | PubMed |
| 13 | 32,796,930 | Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities. | Nat Rev Neurol | 2020 | https://conductscience.org/library/papers/32796930 | PubMed |
| 14 | 31,296,921 | Full sequence of mutant huntingtin 3'-untranslated region and modulation of its gene regulatory activity by endogenous microRNA. | J Hum Genet | 2019 | https://conductscience.org/library/papers/31296921 | PubMed |
| 15 | 17,209,049 | AKT and CDK5/p35 mediate brain-derived neurotrophic factor induction of DARPP-32 in medium size spiny neurons in vitro. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17209049 | PubMed |
| 16 | 22,580,459 | Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis. | Cell Cycle | 2012 | https://conductscience.org/library/papers/22580459 | PubMed |
| 17 | 26,002,103 | CDK5 phosphorylates DRP1 and drives mitochondrial defects in NMDA-induced neuronal death. | Hum Mol Genet | 2015 | https://conductscience.org/library/papers/26002103 | PubMed |
| 18 | 15,854,805 | Tissue distribution, pharmacokinetics and identification of roscovitine metabolites in rat. | Eur J Pharm Sci | 2005 | https://conductscience.org/library/papers/15854805 | PubMed |
| 19 | 32,452,382 | Presynaptic APP levels and synaptic homeostasis are regulated by Akt phosphorylation of huntingtin. | Elife | 2020 | https://conductscience.org/library/papers/32452382 | PubMed |
| 20 | 28,653,853 | Post-Translational Modifications (PTMs), Identified on Endogenous Huntingtin, Cluster within Proteolytic Domains between HEAT Repeats. | J Proteome Res | 2017 | https://conductscience.org/library/papers/28653853 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,850,723 | Huntingtin (HTT) interactome in regulation of DNA repair/remodeling and RNA processing pathways. | Life Sci Alliance | 2026 | https://conductscience.org/library/papers/41850723 | PubMed |
| 40,734,978 | Post-translational modifications orchestrate mTOR-driven cell death in cardiovascular disease. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40734978 | PubMed |
| 39,836,243 | CDK5: Insights into its roles in diseases. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/39836243 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39596381
GET https://conductscience.org/api/papers/v1/39596381/references?page=2